Pub. Date : 2015 Mar
PMID : 25661103
1 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | BACKGROUND: Trastuzumab has been approved for use in combination with fluoropyrimidine plus cisplatin for the treatment of human epidermal growth factor receptor 2 (HER2)-positive advanced gastric cancer (AGC). | Cisplatin | erb-b2 receptor tyrosine kinase 2 | Homo sapiens |